Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
IMMUNEX CORPORATION et al v. SANDOZ INC. et al
Case Number:
2:16-cv-01118
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
August 09, 2019
Amgen Patents Beat Sandoz Validity Check In Biosimilar Fight
A New Jersey federal judge Friday rejected Sandoz Inc.'s attempt to invalidate two patents covering Amgen subsidiary Immunex Corp.'s blockbuster immunosuppressant Enbrel, stalling Sandoz's aim to launch a biosimilar version of the drug.
-
June 21, 2017
Nobel Winner Attacks Sandoz Biosimilar Subpoena
A Nobel Prize-winning researcher has moved to block a Sandoz Inc. subpoena seeking testimony related to a biosimilar of Amgen Inc.'s blockbuster immunosuppressant Enbrel, telling a Texas federal court that the deposition would almost certainly be fruitless.